Allogene Therapeutics ALLO
NASDAQ ALLO
$1.62 -0.01 (-0.61%)
At close: Sep 29, 2026 · 4:00 PM EDT

Allogene Therapeutics (ALLO) Current Assets (2018 - 2026)

Updated

Allogene Therapeutics' Current Assets came in at $340 million for Q2 2026, up 20.3% from $282.66 million a year earlier and up 24.4% from the prior quarter.

Analysis

Allogene Therapeutics (ALLO) Current Assets (2018 - 2026) Analysis & Trends

At the end of FY2025, Allogene Therapeutics' Current Assets was $257.75 million, down 15.0% from FY2024.

  • Current Assets has declined in each of the last three years, with a five-year compound annual growth rate of -21.1% (FY2020 to FY2025).
  • Going back by year, Current Assets was $303.39 million in FY2024 (-33.9%), $459.12 million in FY2023 (-13.2%), $528.82 million in FY2022 (+12.2%) and $471.32 million in FY2021 (-44.2%).
  • The Q2 2026 figure represents the highest quarterly Current Assets since Q2 2024.
  • Year-over-year, Current Assets increased in 1 of the last eight quarters, with an average decline of 18.7%.
  • The fastest year-over-year change in Current Assets over five years came in Q2 2026 (growth of 20.3%), and the weakest in Q4 2021 (a decline of 44.2%).
  • Business Quant data shows ALLO's Current Assets at $273.29 million (Q1 2026), $257.75 million (Q4 2025) and $260.72 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 Allogene Therapeutics 562.91 Mn 562.91 Mn - 340.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 340.00 Mn
Mar 31, 2026 273.29 Mn
Dec 31, 2025 257.75 Mn
Sep 30, 2025 260.72 Mn
Jun 30, 2025 282.66 Mn
Mar 31, 2025 291.58 Mn
Dec 31, 2024 303.39 Mn
Sep 30, 2024 304.42 Mn
Jun 30, 2024 457.12 Mn
Mar 31, 2024 395.36 Mn
Dec 31, 2023 459.12 Mn
Sep 30, 2023 473.45 Mn
Jun 30, 2023 502.10 Mn
Mar 31, 2023 481.47 Mn
Dec 31, 2022 528.82 Mn
Sep 30, 2022 569.06 Mn
Jun 30, 2022 513.03 Mn
Mar 31, 2022 469.74 Mn
Dec 31, 2021 471.32 Mn
Sep 30, 2021 502.86 Mn
API Access

Allogene Therapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=ALLO&period=max&api_key=YOUR_API_KEY